EnzymeBioSystems Financials
We urge to utilize EnzymeBioSystems fundamental analysis to find out if markets are presently mispricing the company. Put another way you can exercise it to find out if EnzymeBioSystems is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze twenty-three available fundamental indicators for EnzymeBioSystems, which can be compared to its peers.
EnzymeBioSystems |
Understanding current and past EnzymeBioSystems Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EnzymeBioSystems' financial statements are interrelated, with each one affecting the others. For example, an increase in EnzymeBioSystems' assets may result in an increase in income on the income statement.
Please note, the presentation of EnzymeBioSystems' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, EnzymeBioSystems' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of EnzymeBioSystems' management manipulating its earnings.
EnzymeBioSystems Stock Summary
EnzymeBioSystems competes with China Shineway, and MedPeerInc. EnzymeBioSystems engages in the contract manufacturing of specialty enzymes and enzyme related products in the United States. The company was founded in 2009 and is headquartered in Las Vegas, Nevada. EnzymeBioSystems operates under Drug Manufacturers - Major classification in USA and traded on OTC Market. It employs 3 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 8250 West Charleston |
| Benchmark | Dow Jones Industrial |
| Website | www.enzymebiosystems.org |
| Phone | 702 907 0615 |
| Currency | USD - US Dollar |
EnzymeBioSystems Key Financial Ratios
EnzymeBioSystems' financial ratios allow both analysts and investors to convert raw data from EnzymeBioSystems' financial statements into concise, actionable information that can be used to evaluate the performance of EnzymeBioSystems over time and compare it to other companies across industries.| Return On Equity | -278.28 | |||
| Return On Asset | -144.51 | |||
| Beta | 2.77 | |||
| Market Capitalization | 559 | |||
| Z Score | -11.2 |
EnzymeBioSystems Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EnzymeBioSystems's current stock value. Our valuation model uses many indicators to compare EnzymeBioSystems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EnzymeBioSystems competition to find correlations between indicators driving EnzymeBioSystems's intrinsic value. More Info.EnzymeBioSystems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value EnzymeBioSystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for EnzymeBioSystems' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in EnzymeBioSystems Pink Sheet
If you are still planning to invest in EnzymeBioSystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EnzymeBioSystems' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |